Literature DB >> 28093023

Sustained employability and health-related quality of life in cancer survivors up to four years after diagnosis.

Saskia F A Duijts1,2, Jacobien M Kieffer2, Peter van Muijen1,3, Allard J van der Beek1,3.   

Abstract

BACKGROUND: Most cancer survivors are able to return to work at some point after diagnosis. However, literature on sustained employability and health-related quality of life (HRQoL) is limited. Therefore, the aims of this study were to explore the influence of change in employment status on HRQoL in cancer survivors long term after diagnosis, and to identify predictors of work continuation in occupationally active survivors.
MATERIAL AND METHODS: We used prospective data (T0 = two years after diagnosis, T1 = one-year follow-up, and T2 = two-year follow-up) from a cohort of cancer survivors that had an employment contract and were of working age at T0 (N = 252, 69.8% female). Groups were formed on the basis of change in employment status: 'continuously not working' (19.8%), 'positive change in employment status' (5.6%), 'negative change in employment status' (14.7%), and 'continuously working' (59.9%). ANCOVA was used to explore the relationship between change in employment status and HRQoL at T1. Generalized estimating equations (GEE) were used to identify predictors of work continuation (at T1 and T2) in survivors that were occupationally active at T0 (N = 212).
RESULTS: 'Continuously working' survivors scored significantly better on the EORTC QLQ-C30 scales: role functioning, fatigue, pain, constipation, global health/QoL and the Summary score, than 'continuously not working' survivors, and better on physical, role and emotional functioning, fatigue, financial impact, global health/QoL and the Summary score than survivors with a 'negative change in employment status' (effect size range = 0.49-0.74). In occupationally active survivors, a high score on current work ability was associated with work continuation one year later [odds ratio (OR) 1.46; 95% CI 1.11-1.92].
CONCLUSION: Cancer survivors 'continuously working' function better and have a better health and QoL than those who are not able to work. However, in occupationally active cancer survivors, one should monitor those with low self-perceived work ability, because they have an increased risk to discontinue their work.

Entities:  

Mesh:

Year:  2017        PMID: 28093023     DOI: 10.1080/0284186X.2016.1266083

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  25 in total

1.  Factors influencing return to work of cancer survivors: a population-based study in Italy.

Authors:  Sara Paltrinieri; Massimo Vicentini; Elisa Mazzini; Elena Ricchi; Stefania Fugazzaro; Pamela Mancuso; Paolo Giorgi Rossi; Stefania Costi
Journal:  Support Care Cancer       Date:  2019-05-25       Impact factor: 3.603

2.  Return to work in European Cancer survivors: a systematic review.

Authors:  Sara Paltrinieri; Stefania Fugazzaro; Lucia Bertozzi; Maria Chiara Bassi; Martina Pellegrini; Massimo Vicentini; Elisa Mazzini; Stefania Costi
Journal:  Support Care Cancer       Date:  2018-05-29       Impact factor: 3.603

3.  Managing work and cancer treatment: Experiences among survivors of hematological cancer.

Authors:  Maria D Thomson; Laura A Siminoff
Journal:  Cancer       Date:  2018-04-16       Impact factor: 6.860

4.  Neuropsychological test performance and self-reported cognitive functioning associated with work-related outcomes in occupationally active cancer survivors with cognitive complaints.

Authors:  Kete M Klaver; Saskia F A Duijts; Chantal A V Geusgens; Maureen J B Aarts; Rudolf W H M Ponds; Allard J van der Beek; Sanne B Schagen
Journal:  J Cancer Surviv       Date:  2022-07-01       Impact factor: 4.442

5.  Multimorbidity and Employment Outcomes Among Middle-Aged US Cancer Survivors.

Authors:  Christine C Ekenga; BoRin Kim; Eunsun Kwon; Sojung Park
Journal:  J Occup Environ Med       Date:  2022-06-01       Impact factor: 2.306

6.  Recommendations for Research and Practice to Improve Work Outcomes Among Cancer Survivors.

Authors:  Janet S de Moor; Catherine M Alfano; Erin E Kent; Wynne E Norton; Diarmuid Coughlan; Megan C Roberts; Melvin Grimes; Cathy J Bradley
Journal:  J Natl Cancer Inst       Date:  2018-10-01       Impact factor: 13.506

7.  Survivorship, Version 1.2021.

Authors:  Amye Tevaarwerk; Crystal S Denlinger; Tara Sanft; Shannon M Ansbaugh; Saro Armenian; K Scott Baker; Gregory Broderick; Andrew Day; Wendy Demark-Wahnefried; Kristin Dickinson; Debra L Friedman; Patricia Ganz; Mindy Goldman; Norah Lynn Henry; Christine Hill-Kayser; Melissa Hudson; Nazanin Khakpour; Divya Koura; Allison L McDonough; Michelle Melisko; Kathi Mooney; Halle C F Moore; Natalie Moryl; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Chirayu Patel; Lindsay Peterson; William Pirl; M Alma Rodriguez; Kathryn J Ruddy; Lidia Schapira; Lillie Shockney; Sophia Smith; Karen L Syrjala; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2021-06-30       Impact factor: 11.908

8.  Trajectories of Cognitive Symptoms in Sick-Listed Cancer Survivors.

Authors:  Kete M Klaver; Sanne B Schagen; Jacobien M Kieffer; Allard J van der Beek; Saskia F A Duijts
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

9.  Perspectives on returning to work of multiple myeloma patients: A qualitative interview study.

Authors:  Christine Bennink; Marjolein van der Klift; Hans Scheurer; Pieter Sonneveld; Saskia F A Duijts
Journal:  Eur J Cancer Care (Engl)       Date:  2021-06-21       Impact factor: 2.328

10.  Predictors for earlier return to work of cancer patients.

Authors:  M D J Wolvers; M C J Leensen; I F Groeneveld; M H W Frings-Dresen; A G E M De Boer
Journal:  J Cancer Surviv       Date:  2017-10-26       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.